Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03346655 : Brain Metastases in Norway
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Verified cancer diagnosis of solid tumors (based on radiological,
histological/cytological or operative evidence).

- Brain metastases verified by computer tomography (CT), contrast-enhanced magnetic
resonance imaging (MRI), or surgical biopsies

- Age ? 18 years

- Able to comply with study procedures

- Able to provide written informed consent after information in Norwegian

Exclusion Criteria:

- Primary brain tumors

- Primary hematological malignancies (lymphomas, leukemias)

- Previous diagnosis and/or treatment of BM

- Unable to produce written informed consent after information in Norwegian
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT03346655      |      Link to official Clinicaltrials.gov listing
Locations
Oslo,
Norway

Facility: Oslo University Hospital
Investigator:
Contact: Olav E Yri, MD, PhD Phone: +47 22 93 40 00
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites